Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,548Revenue $M934Net Margin (%)-5.6Z-Score1.3
Enterprise Value $M9,951EPS $2.2Operating Margin %1.9F-Score5
P/E(ttm))0Cash Flow Per Share $3.6Pre-tax Margin (%)-8.6Higher ROA y-yN
Price/Book14.210-y EBITDA Growth Rate %0Quick Ratio0.8Cash flow > EarningsY
Price/Sales5.75-y EBITDA Growth Rate %0Current Ratio0.9Lower Leverage y-yY
Price/Cash Flow11.8y-y EBITDA Growth Rate %-30.0ROA % (ttm)-2.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-11.3Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M63.7ROI % (ttm)2.6Gross Margin Increase y-yN

Gurus Latest Trades with SLXP

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SLXPAndreas Halvorsen 2014-06-30 Add0.74%$97.7 - $125.07
($110.33)
$ 114.494%Add 86.19%2,889,303
SLXPJoel Greenblatt 2014-06-30 Sold Out -0.48%$97.7 - $125.07
($110.33)
$ 114.494%Sold Out0
SLXPAndreas Halvorsen 2014-03-31 Buy 0.67%$88.8 - $114.64
($101.95)
$ 114.4912%New holding, 1551766 sh.1,551,766
SLXPJoel Greenblatt 2014-03-31 Buy 0.48%$88.8 - $114.64
($101.95)
$ 114.4912%New holding, 307445 sh.307,445
SLXPJoel Greenblatt 2013-09-30 Sold Out -0.36%$65.73 - $75.54
($68.97)
$ 114.4966%Sold Out0
SLXPJoel Greenblatt 2013-06-30 Buy 0.36%$47.72 - $66.83
($57.19)
$ 114.49100%New holding, 127495 sh.127,495
SLXPVanguard Health Care Fund 2013-03-31 Add0.08%$40.472 - $51.37
($47.96)
$ 114.49139%Add 22.44%2,147,945
SLXPJoel Greenblatt 2013-03-31 Sold Out -0.15%$40.472 - $51.37
($47.96)
$ 114.49139%Sold Out0
SLXPJoel Greenblatt 2012-12-31 Add0.06%$37.97 - $42.9
($40.82)
$ 114.49180%Add 75.81%63,399
SLXPNWQ Managers 2012-12-31 Sold Out -0.17%$37.97 - $42.9
($40.82)
$ 114.49180%Sold Out0
SLXPJoel Greenblatt 2012-09-30 Buy 0.1%$41.92 - $55.65
($47.44)
$ 114.49141%New holding, 36061 sh.36,061
SLXPNWQ Managers 2012-03-31 Reduce-0.14%$45.72 - $53.75
($46.12)
$ 114.49148%Reduce -40.33%656,533
SLXPNWQ Managers 2011-09-30 Add0.18%$26.18 - $40.9
($33.07)
$ 114.49246%Add 198.07%1,320,679
SLXPVanguard Health Care Fund 2011-09-30 Add0.09%$26.18 - $40.9
($33.07)
$ 114.49246%Add 55.43%1,554,300
SLXPJohn Paulson 2011-09-30 Sold Out -0.2056%$26.18 - $40.9
($33.07)
$ 114.49246%Sold Out0
SLXPJohn Paulson 2011-06-30 Add0.19%$34.69 - $40.57
($37.85)
$ 114.49202%Add 971.43%1,500,000
SLXPNWQ Managers 2011-06-30 Buy 0.09%$34.69 - $40.57
($37.85)
$ 114.49202%New holding, 443084 sh.443,084
SLXPGeorge Soros 2011-06-30 Sold Out $34.69 - $40.57
($37.85)
$ 114.49202%Sold Out0
SLXPJohn Paulson 2011-03-31 Buy 0.01%$31.61 - $48.03
($38.86)
$ 114.49195%New holding, 140000 sh.140,000
SLXPGeorge Soros 2011-03-31 Reduce$31.61 - $48.03
($38.86)
$ 114.49195%Reduce -95.44%5,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SLXP is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SLXP Andreas Halvorsen 2014-09-302,719,5384.271.7-5.88%
SLXP Vanguard Health Care Fund 2014-09-301,538,0452.410.61-15.7%
Premium Most recent portfolio changes are included for Premium Members only!


SLXP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Forbes William PEVP Research&Devel & CDO 2014-11-12Sell11,079$95.0515.84view
CREECH TIMOTHY JSee Remarks 2014-11-05Sell0$015.84view
LOGAN CAROLYN JPresident & CEO 2014-06-26Sell53,057$123.38-10.76view
Scruggs Rick DExecutive Vice President 2014-05-16Sell900$105.674.2view
D ALONZO THOMASDirector 2014-04-22Sell11,530$110.89-0.7view
Scruggs Rick DExecutive Vice President 2014-03-04Sell1,319$110.66-0.5view
CHAPPELL JOHN FDirector 2014-03-04Sell10,000$112.2-1.86view
D ALONZO THOMASDirector 2014-01-10Sell12,050$91.8319.91view
DERBYSHIRE ADAM CEVP Finance/CFO 2014-01-09Sell30,001$91.4820.37view
Forbes William PEVP Research&Devel & CDO 2014-01-08Sell8,000$90.0622.26view

Press Releases about SLXP :

Quarterly/Annual Reports about SLXP:

News about SLXP:

Articles On GuruFocus.com
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Salix Pharmaceu Dec 12 2014 
Pharmaceutical Giant Merck Buys Cubist Pharma Dec 09 2014 
Bill Ackman and Valeant Could Sweeten Allergan Deal By $15 A Share Oct 10 2014 
Steven Cohen Has a Track Record of Impressive Returns Jul 31 2014 
Joel Greenblatt's Gotham Capital Top 5 New Stocks May 16 2014 
Weekly CFO Sells Highlight: FII, SLXP, CCK, VCI, WDC, STMP Dec 31 2012 
Weekly Guru Bargains Highlights: HMSY, FB, TSU, SLXP, ANR Oct 29 2012 
Value Shop Nuveen Investments Reports Second Quarter Portfolio Aug 19 2011 
Hedge Fund Giant John Paulson Reports Q2 Portfolio Aug 15 2011 
Salix Pharmaceuticals Ltd. (SLXP) President & CEO Carolyn J Logan sells 14,000 Shares Sep 23 2010 


More From Other Websites
Nasdaq stocks posting largest percentage decreases Dec 16 2014
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From... Dec 16 2014
SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Dec 16 2014
Salix Limits Sales of Top Drugs to Let Wholesalers Cut Inventory Dec 16 2014
Salix Destocking Plan, 2-Year Guidance Soothe Street Dec 16 2014
Salix to Clear Wholesaler Inventory, Withdraws Guidance Dec 16 2014
Salix to fix inventory pile-up by end of 2015 Dec 16 2014
Salix Pharmaceuticals Provides Updates on Wholesaler Inventory Reductions and the XIFAXAN® 550 for... Dec 16 2014
7:02 am Salix Pharma is working cooperatively with its principal pharmaceutical wholesalers to... Dec 16 2014
Salix Pharmaceuticals Provides Updates on Wholesaler Inventory Reductions and the XIFAXAN® 550 for... Dec 16 2014
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Salix... Dec 12 2014
SECURITIES ALERT: Rosen Law Firm Reminds Salix Pharmaceuticals, Ltd. Shareholders of Important... Dec 11 2014
Can Salix Pharmaceuticals (SLXP) Run Higher on Strong Earnings Estimate Revisions? Dec 11 2014
Lieff Cabraser Reminds Salix Pharmaceuticals, Inc. Investors of Upcoming Deadline in Class Action... Dec 10 2014
Ironwood Pharmaceuticals Advances IW-9179 to Phase IIa Dec 10 2014
SLXP SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Salix... Dec 09 2014
Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against Salix... Dec 09 2014
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Dec 05 2014
SLXP SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Salix... Dec 02 2014
Sterne Agee Says Salix Pharmaceuticals Accounting Concerns Are 'Overdone' Dec 02 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK